Related Experiment Video

Updated: May 21, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Outcomes of extremely low birth weight infants given early high-dose erythropoietin

R M McAdams1, R J McPherson, D E Mayock

  • 1Department of Pediatrics, Division of Neonatology, University of Washington, Seattle, WA 98195-6320, USA.

Journal of Perinatology : Official Journal of the California Perinatal Association
|June 23, 2012
PubMed

Insights

High-dose erythropoietin (Epo) treatment in extremely low birth weight (ELBW) infants appears safe and may modestly improve neurodevelopmental outcomes. Long-term follow-up showed no adverse effects in ELBW infants receiving Epo.

Area of Science:

  • Neonatal Medicine
  • Developmental Pediatrics

Background:

  • Extremely low birth weight (ELBW) infants face significant risks for adverse neurodevelopmental outcomes.
  • Erythropoietin (Epo) has been investigated for its potential neuroprotective effects in preterm infants.

Purpose of the Study:

  • To assess the long-term safety and neurodevelopmental outcomes of ELBW infants treated with high-dose erythropoietin (Epo).

Main Methods:

  • Retrospective analysis of 60 ELBW infants (30 treated with high-dose Epo, 30 controls).
  • Evaluation of anthropometric and neurodevelopmental data from birth up to 36 months.
  • Statistical analysis using multiple linear regression to identify correlations between Epo treatment and outcomes.

Main Results:

  • Birth characteristics and growth trajectories were comparable between Epo-treated and control groups.
  • Epo treatment correlated with modest improvements in cognitive and motor scores at follow-up.
  • No significant adverse long-term effects were observed in infants who received Epo.

Conclusions:

  • High-dose Epo treatment in ELBW infants is associated with favorable long-term safety.
  • Epo administration may offer a modest benefit for neurodevelopmental outcomes in this vulnerable population.
Abstract

More Related Videos

Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis06:40

Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis

Published on: September 9, 2014

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells14:22

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells

Published on: July 16, 2011

Related Concept Videos

Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...